Pfizer Inc (PFE)
25.63
+0.50
(+1.99%)
USD |
NYSE |
Nov 22, 16:00
25.60
-0.03
(-0.12%)
After-Hours: 20:00
Pfizer Free Cash Flow (Quarterly): 6.063B for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.063B |
| June 30, 2024 | -2.418B |
| March 31, 2024 | 386.00M |
| December 31, 2023 | 4.196B |
| September 30, 2023 | 2.646B |
| June 30, 2023 | -2.122B |
| March 31, 2023 | 73.00M |
| December 31, 2022 | 7.581B |
| September 30, 2022 | 5.133B |
| June 30, 2022 | 7.419B |
| March 31, 2022 | 5.898B |
| December 31, 2021 | 4.912B |
| September 30, 2021 | 10.21B |
| June 30, 2021 | 10.76B |
| March 31, 2021 | 3.984B |
| December 31, 2020 | 4.812B |
| September 30, 2020 | 1.583B |
| June 30, 2020 | 3.098B |
| March 31, 2020 | 2.684B |
| December 31, 2019 | 3.591B |
| September 30, 2019 | 3.848B |
| June 30, 2019 | 2.023B |
| March 31, 2019 | 1.08B |
| December 31, 2018 | 4.006B |
| September 30, 2018 | 4.697B |
| Date | Value |
|---|---|
| June 30, 2018 | 3.423B |
| March 31, 2018 | 1.565B |
| December 31, 2017 | 6.316B |
| September 30, 2017 | 4.292B |
| June 30, 2017 | 2.751B |
| March 31, 2017 | 1.226B |
| December 31, 2016 | 5.272B |
| September 30, 2016 | 4.305B |
| June 30, 2016 | 3.109B |
| March 31, 2016 | 1.507B |
| December 31, 2015 | 4.236B |
| September 30, 2015 | 4.695B |
| June 30, 2015 | 3.827B |
| March 31, 2015 | 434.00M |
| December 31, 2014 | 5.203B |
| September 30, 2014 | 3.902B |
| June 30, 2014 | 3.759B |
| March 31, 2014 | 2.637B |
| December 31, 2013 | 5.225B |
| September 30, 2013 | 5.572B |
| June 30, 2013 | 3.447B |
| March 31, 2013 | 1.975B |
| December 31, 2012 | 4.362B |
| September 30, 2012 | 4.718B |
| June 30, 2012 | 3.727B |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-2.418B
Minimum
Jun 2024
10.76B
Maximum
Jun 2021
4.025B
Average
4.09B
Median
Free Cash Flow (Quarterly) Benchmarks
| Amgen Inc | 3.314B |
| Johnson & Johnson | 5.714B |
| Eli Lilly and Co | -458.90M |
| Merck & Co Inc | 8.508B |
| Moderna Inc | -1.717B |